Fmr LLC10% Owner
Sell $62.5M of disclosed value in Beam Therapeutics Inc. $BEAM.
Sell
Biotech & Oncology
Last updated
Jun 30, 2026
Based on
153 actions
Gurus considered
144
Stocks covered
547
Biotechnology, oncology, immunology, genetic medicines, and clinical-stage therapeutics. This page tracks 153 investor, Congress, and insider actions tied to Biotech & Oncology within Healthcare Innovation, connecting the industry classification with the people and institutions currently showing activity. It gives context from 144 gurus across 547 stocks, so the feed can be read as an industry-level signal rather than a loose list of single-stock events.
Biotech & Oncology Smart Money Notes
Rosenman HermDirector
Sell $4.1M of disclosed value in Natera, Inc. $NTRA.
Sell
Lewis WilliamDirector, Chair & CEO
Sell $173.3M of disclosed value in Insmed Incorporated $INSM.
Sell
Rabinowitz DanielSEC. & CLO
Sell $260.8M of disclosed value in Natera, Inc. $NTRA.
Sell
Anders JackCFO
Sell $78.8M of disclosed value in Revolution Medicines, Inc. $RVMD.
Sell
Booth BruceDirector
Sell $12.5B of disclosed value in Kymera Therapeutics, Inc. $KYMR.
Sell
Rothblatt Martine ADirector, Chair & CEO
Sell $846.3M of disclosed value in United Therapeutics Corporation $UTHR.
Sell
Fairmount Funds Management LLCInstitutional Owner
Sell $399.7M of disclosed value in Spyre Therapeutics, Inc. $SYRE.
Sell
Kapusta Matthew CDirector, CEO, Managing Director
Sell $216M of disclosed value in uniQure N.V. $QURE.
Sell
Henderson Michael ThomasDirector
Sell $2.0M of disclosed value in Spyre Therapeutics, Inc. $SYRE.
Sell
Robins Harlan SCSO
Sell $47.3M of disclosed value in Adaptive Biotechnologies Corporation $ADPT.
Sell
Ra Capital Management, L.p.10% Owner
Buy $510.8M of disclosed value in Artiva Biotherapeutics, Inc. $ARTV.
Buy
Kumar NeilDirector, CEO
Sell $40M of disclosed value in BRIDGEBIO PHARMA INC $BBIO.
Sell
Stapley MarcDirector, CEO
Sell $6.9M of disclosed value in Veracyte Inc $VCYT.
Sell
Krishnan SumaDirector, President, R & D, 10% Owner
Sell $6.6M of disclosed value in Krystal Biotech, Inc. $KRYS.
Sell
Edgemond JamesCFO & TREASURER
Sell $193.8M of disclosed value in United Therapeutics Corporation $UTHR.
Sell
Krishnan Krish SDirector, President & CEO, 10% Owner
Sell $6.7M of disclosed value in Krystal Biotech, Inc. $KRYS.
Sell
Chapman Steven LeonardDirector, CEO & President
Sell $67.9M of disclosed value in Natera, Inc. $NTRA.
Sell
Krognes Steve E.Director
Sell $1.2M of disclosed value in Guardant Health, Inc. $GH.
Sell
Randhawa SimratEVP, Head of R & D
Sell $2.4M of disclosed value in Dianthus Therapeutics, Inc. $DNTH.
Sell
Orbimed Advisors LLC10% Owner
Buy $15M of disclosed value in Q32 Bio Inc. $QTTB.
Buy
Sukhtian Ghiath M.Director, 10% Owner
Buy $12M of disclosed value in Outlook Therapeutics, Inc. $OTLK.
Buy
Xu DiyongDirector, 10% Owner
Buy $15M of disclosed value in Q32 Bio Inc. $QTTB.
Buy
Fromkin Andrew J.Director
Sell $12.3M of disclosed value in Immunovant, Inc. $IMVT.
Sell
Lefkofsky Eric PDirector, CEO & Chair, 10% Owner
Sell $5.1B of disclosed value in TEMPUS AI INC $TEM.
Sell
Brynjelsen SeanDirector, President & CEO
Sell $3.8M of disclosed value in Eton Pharmaceuticals, Inc. $ETON.
Sell
AWM Investment Company, Inc.10% Owner
Sell $1.5M of disclosed value in 908 Devices Inc. $MASS.
Sell
Satter Muneer ADirector
Buy $3.3M of disclosed value in Annexon, Inc. $ANNX.
Buy
GC Corp.10% Owner
Buy $51.3M of disclosed value in Artiva Biotherapeutics, Inc. $ARTV.
Buy
Durcan Dermot MarkDirector
Buy $1.1M of disclosed value in Cencora Inc $COR.
Buy
Showing 1-30 of 153